BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29073019)

  • 1. Structure and dynamics of the RNAPII CTDsome with Rtt103.
    Jasnovidova O; Klumpler T; Kubicek K; Kalynych S; Plevka P; Stefl R
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11133-11138. PubMed ID: 29073019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different phosphoisoforms of RNA polymerase II engage the Rtt103 termination factor in a structurally analogous manner.
    Nemec CM; Yang F; Gilmore JM; Hintermair C; Ho YH; Tseng SC; Heidemann M; Zhang Y; Florens L; Gasch AP; Eick D; Washburn MP; Varani G; Ansari AZ
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E3944-E3953. PubMed ID: 28465432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA polymerase II C-terminal domain-interacting domain of yeast Nrd1 contributes to the choice of termination pathway and couples to RNA processing by the nuclear exosome.
    Heo DH; Yoo I; Kong J; Lidschreiber M; Mayer A; Choi BY; Hahn Y; Cramer P; Buratowski S; Kim M
    J Biol Chem; 2013 Dec; 288(51):36676-90. PubMed ID: 24196955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain.
    Lunde BM; Reichow SL; Kim M; Suh H; Leeper TC; Yang F; Mutschler H; Buratowski S; Meinhart A; Varani G
    Nat Struct Mol Biol; 2010 Oct; 17(10):1195-201. PubMed ID: 20818393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into recognition of phosphorylated threonine-4 of RNA polymerase II C-terminal domain by Rtt103p.
    Jasnovidova O; Krejcikova M; Kubicek K; Stefl R
    EMBO Rep; 2017 Jun; 18(6):906-913. PubMed ID: 28468956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of RNA polymerase II carboxy-terminal domain by 3'-RNA-processing factors.
    Meinhart A; Cramer P
    Nature; 2004 Jul; 430(6996):223-6. PubMed ID: 15241417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub1 contacts the RNA polymerase II stalk to modulate mRNA synthesis.
    Garavís M; González-Polo N; Allepuz-Fuster P; Louro JA; Fernández-Tornero C; Calvo O
    Nucleic Acids Res; 2017 Mar; 45(5):2458-2471. PubMed ID: 27924005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of Ctk3, a subunit of the RNA polymerase II CTD kinase complex, reveals a noncanonical CTD-interacting domain fold.
    Mühlbacher W; Mayer A; Sun M; Remmert M; Cheung AC; Niesser J; Soeding J; Cramer P
    Proteins; 2015 Oct; 83(10):1849-58. PubMed ID: 26219431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RPRD1A and RPRD1B are human RNA polymerase II C-terminal domain scaffolds for Ser5 dephosphorylation.
    Ni Z; Xu C; Guo X; Hunter GO; Kuznetsova OV; Tempel W; Marcon E; Zhong G; Guo H; Kuo WW; Li J; Young P; Olsen JB; Wan C; Loppnau P; El Bakkouri M; Senisterra GA; He H; Huang H; Sidhu SS; Emili A; Murphy S; Mosley AL; Arrowsmith CH; Min J; Greenblatt JF
    Nat Struct Mol Biol; 2014 Aug; 21(8):686-695. PubMed ID: 24997600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Analysis of Phosphorylation Sites on the Rpb1 C-Terminal Domain of RNA Polymerase II.
    Suh H; Ficarro SB; Kang UB; Chun Y; Marto JA; Buratowski S
    Mol Cell; 2016 Jan; 61(2):297-304. PubMed ID: 26799764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key features of the interaction between Pcf11 CID and RNA polymerase II CTD.
    Noble CG; Hollingworth D; Martin SR; Ennis-Adeniran V; Smerdon SJ; Kelly G; Taylor IA; Ramos A
    Nat Struct Mol Biol; 2005 Feb; 12(2):144-51. PubMed ID: 15665873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rtr1 is a dual specificity phosphatase that dephosphorylates Tyr1 and Ser5 on the RNA polymerase II CTD.
    Hsu PL; Yang F; Smith-Kinnaman W; Yang W; Song JE; Mosley AL; Varani G
    J Mol Biol; 2014 Aug; 426(16):2970-81. PubMed ID: 24951832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the recognition of RNA polymerase II C-terminal domain by CREPT and p15RS.
    Mei K; Jin Z; Ren F; Wang Y; Chang Z; Wang X
    Sci China Life Sci; 2014 Jan; 57(1):97-106. PubMed ID: 24399136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTD tyrosine phosphorylation impairs termination factor recruitment to RNA polymerase II.
    Mayer A; Heidemann M; Lidschreiber M; Schreieck A; Sun M; Hintermair C; Kremmer E; Eick D; Cramer P
    Science; 2012 Jun; 336(6089):1723-5. PubMed ID: 22745433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural heterogeneity in the intrinsically disordered RNA polymerase II C-terminal domain.
    Portz B; Lu F; Gibbs EB; Mayfield JE; Rachel Mehaffey M; Zhang YJ; Brodbelt JS; Showalter SA; Gilmour DS
    Nat Commun; 2017 May; 8():15231. PubMed ID: 28497792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II.
    Kim M; Krogan NJ; Vasiljeva L; Rando OJ; Nedea E; Greenblatt JF; Buratowski S
    Nature; 2004 Nov; 432(7016):517-22. PubMed ID: 15565157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heptad-Specific Phosphorylation of RNA Polymerase II CTD.
    Schüller R; Forné I; Straub T; Schreieck A; Texier Y; Shah N; Decker TM; Cramer P; Imhof A; Eick D
    Mol Cell; 2016 Jan; 61(2):305-14. PubMed ID: 26799765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting phosphorylation-dependent interactions with the C-terminal domain of RNA polymerase II subunit Rpb1p using a yeast two-hybrid assay.
    Ursic D; Finkel JS; Culbertson MR
    RNA Biol; 2008; 5(1):1-4. PubMed ID: 18388493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rtr1 is a CTD phosphatase that regulates RNA polymerase II during the transition from serine 5 to serine 2 phosphorylation.
    Mosley AL; Pattenden SG; Carey M; Venkatesh S; Gilmore JM; Florens L; Workman JL; Washburn MP
    Mol Cell; 2009 Apr; 34(2):168-78. PubMed ID: 19394294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.